NFKB1 and diffuse large B-cell lymphoma: By further study of the potential impact of a TLR9 inhibitor on ABC and GCB cell lines, we present initial preliminary results of a possible effect on ABC DLBCL cell growth in vitro linked to NF-kB de-activation.